Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

NZ Tech Company Volpara Health Expands Further Into U.S.

Wellington-based Volpara Health, has hit 2021 running with the acquisition of a breast cancer risk assessment company in Boston, CRA Health.

Volpara Health, which is listed on the ASX, is a health technology software company whose integrated breast care platform assists in the delivery of personalised patient care.

CRA is a spinoff from Massachusetts General Hospital — a Harvard Medical School teaching hospital.

Volpara believes the combination will deliver personalised breast care to more women across the world – especially vital in the covid era where traditional screening has been delayed for many women.

Volpara is paying US$18.0M to acquire all outstanding equity of CRA, with a further US$4.0M payable upon its meeting key performance targets over the next 18 months.

CRA Health has been singularly focused on cancer risk assessment for more than 15 years and conducts more than two million assessments annually. CRA, which is cloud based, receives patient information, including breast density, and returns the risk of breast cancer alongside appropriate recommendations.

CRA Health and Volpara Health – both born out of scientific research at Harvard Medical School and Oxford – have long shared the common mission of saving more families from cancer and have already collaborated on major projects.

For more than a decade, Volpara’s science, a set of clinically validated algorithms that use AI to assess breast tissue composition and imaging quality, has helped breast centres in NZ, Australia and the U.S to optimise mammography workflow and deliver personalized care.

Dr. Ralph Highnam, Group CEO of Volpara, says “the acquisition of CRA is very significant for Volpara. CRA is a leading provider of risk assessment tools within major Electronic Health Record (EHR) systems and has integrations already built with the main genetics companies. CRA brings world-class knowledge about risk & genetics. CRA will accelerate us on our mission to save families from cancer by preventing advanced stage breast cancer.”

“Combining the two companies will allow us to identify and deliver personalised breast care to more high-risk women,” says Dr Highnam.

Both CRA and Volpara have experienced strong growth despite the pandemic, signaling the value placed on using evidence to medically necessitate genetic testing and additional imaging.

Volpara Health recently reported its largest-ever third quarter sales performance with an Annual Recurring Revenue (ARR) of US$13.5M — up 20% compared to the previous corresponding period — driven by increasing demand for the Volpara Breast Health Platform.

About Volpara Health

Volpara provides an advanced AI software platform that works with a healthcare provider's expertise to more efficiently enable a high-quality, optimised, and personalised cancer screening experience.

From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient's breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities.

These capabilities are being extended to lung cancer screening.

The Volpara Breast Health Platform is supported by numerous patents, trademarks, and regulatory registrations, including FDA clearance and CE marking, and is validated by a volume of peer-reviewed publications unrivaled in the breast screening industry.

For more information, visit https://www.volparahealth.com

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 


Government: David McLean Appointed As KiwiRail Chair

David McLean has been appointed as Chair of KiwiRail Holdings Ltd, the Minister for State Owned Enterprises Dr David Clark and Minister of Finance Grant Robertson announced today... More>>


Dairy NZ: ‘More Milk From Fewer Cows’ Trend Continues In A Record Year
Vodafone says it has 10,000 customers using its Wi-Fi Calling service. It took less than three months to reach that milestone; the service began operating in September... More>>

Statistics: Consents Remain At Record Levels
There were 47,715 new homes consented in the year ended October 2021, up 26 percent compared with the year ended October 2020, Stats NZ said today. "The year ended October 2021 marks another record for the annual number of new homes consented,” construction statistics manager Michael Heslop said... More>>



Fonterra: Lifts Forecast Farmgate Milk Price Range And Revises Earnings Guidance At First Quarter Update

Fonterra Co-operative Group today lifted its 2021/22 forecast Farmgate Milk Price range, reported a solid start to the 2022 financial year and revised its earnings guidance... More>>


Canterbury Museum: New Research - Bald Haast's Eagle Feasted On Moa Guts

New Zealand’s extinct Haast’s Eagle (Hieraaetus moorei), the largest known eagle, gulped down viscera like a vulture and may even have been bald, new research suggests... More>>

ABC Business Sales: Demand High For Covid-proof Businesses
Despite the continuing challenges facing businesses in this Covid environment, right now there are more buyers looking for a small-medium sized business than there are sellers in the market... More>>


PriceSpy: Producer Prices Increase
New Black Friday and Covid-19 Report* released by PriceSpy says people’s fear of stepping inside physical shops during big sales events like Black Friday has risen since last year; Kiwis are still planning to shop, but more than ever will do it online this year... More>>